Bleeding in patients with Budd–Chiari syndrome

DeLeve, 2009, Vascular disorders of the liver, Hepatology, 49, 1729, 10.1002/hep.22772 Zeitoun, 1999, Outcome of Budd–Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting, Hepatology, 30, 84, 10.1002/hep.510300125 Janssen, 2003, Budd–Chiari syndrome: a review by an expert panel, J Hepatol, 38, 364, 10.1016/S0168-8278(02)00434-8 de Franchis, 2005, Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 43, 167, 10.1016/j.jhep.2005.05.009 Eapen, 2006, Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome, Gut, 55, 878, 10.1136/gut.2005.071423 Plessier, 2006, Aiming at minimal invasiveness as a therapeutic strategy for Budd–Chiari syndrome, Hepatology, 44, 1308, 10.1002/hep.21354 Linkins, 2003, Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis, Ann Intern Med, 139, 893, 10.7326/0003-4819-139-11-200312020-00007 Rautou, 2009, Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd–Chiari syndrome, Clin Gastroenterol Hepatol, 7, 1230, 10.1016/j.cgh.2009.06.011 Rautou, 2009, Prognostic indices for Budd–Chiari syndrome: valid for clinical studies but insufficient for individual management, Am J Gastroenterol, 104, 1140, 10.1038/ajg.2009.63 Ansell, 2008, Pharmacology and management of the vitamin K antagonists: American College of chest physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 160S, 10.1378/chest.08-0670 Kearon, 2008, Antithrombotic therapy for venous thromboembolic disease: American College of chest physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 454S, 10.1378/chest.08-0658 Garcia-Pagan, 2008, TIPS for Budd–Chiari syndrome: long-term results and prognostics factors in 124 patients, Gastroenterology, 135, 808, 10.1053/j.gastro.2008.05.051 Mentha, 2006, Liver transplantation for Budd–Chiari syndrome: a European study on 248 patients from 51 centres, J Hepatol, 44, 520, 10.1016/j.jhep.2005.12.002 Mancuso, 2003, TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience, J Hepatol, 38, 751, 10.1016/S0168-8278(03)00118-1 Kitchens, 2007, Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe, J Thromb Thrombolysis, 23, 223, 10.1007/s11239-006-9017-4 Garcia-Tsao, 2007, Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis, Hepatology, 46, 922, 10.1002/hep.21907 Gonzalez, 2008, Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis, Ann Intern Med, 149, 109, 10.7326/0003-4819-149-2-200807150-00007 De Gottardi, 2009, Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study, Clin Gastroenterol Hepatol, 7, 906, 10.1016/j.cgh.2009.05.004 Murad, 2004, Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome, Hepatology, 39, 500, 10.1002/hep.20064